RS Research

Targeted Drug Delivery Platform For Oncology

Founded: Founded 2015
Locations: 1 location

RS Research

Targeted Drug Delivery Platform For Oncology

Founded: Founded 2015
Locations: 1 location

About

RS Research is a clinical-stage biotechnology company discovering and developing smart nanomedicines for targeted cancer therapies. Its proprietary Sagitta® platform technology uses polymer-drug conjugates to selectively deliver payloads to tumor tissue, improving the therapeutic index and disrupting the efficacy-toxicity trade-off in solid tumors.

Services

Pre-Clinical ADME and Toxicology Services

Provides pre-clinical ADME and toxicology studies to support pharmaceutical lead candidate selection and clinical development. Services include bioavailability, pharmacokinetic (PK), and biodistribution studies, alongside in vivo acute and chronic toxicity screening in experimental animals to evaluate systemic exposure and safety pharmacology.

Bioanalytical and Analytical Testing

Offers quantitative bioanalytical method development, validation, stability testing, and impurity/metabolite analysis for compounds ranging from small molecules to large proteins and biosimilars. These analytical testing solutions support bio-equivalence studies, impurity profiling, and regulatory validation.

GMP Oncology Drug Manufacturing

Provides clinical-batch production of oncology drugs under strict GMP-compliant procedures in a certified facility. Specializes in the synthesis, development, and filling of investigational injectable drugs, including cytotoxic, cytostatic, and highly potent active pharmaceutical ingredients (APIs), aseptic liquid filling, and lyophilization.